INSIDERFilingvia Quantisnow
Neuraxis Inc. logo

Neuraxis (NRXS) CEO Carrico received 193,329 RSU

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Brian Allen Carrico (Chief Executive Officer at Neuraxis Inc., NRXS) reported that they received 193,329 RSU on Aug 13, 2026.

Reporting person
Carrico Brian Allen
Role
Chief Executive Officer

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Aug 13, 2026Grant or award (A)RSUOn 193,329 Common Stock1+193,329$6.28$1.21M193,329 direct

Holdings before and after

  • RSU: 0 to 193,329 direct

Footnotes from the filing

  1. 1. These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Carrico report in this NRXS Form 4?

Brian Allen Carrico (Chief Executive Officer at Neuraxis Inc., NRXS) reported that they received 193,329 RSU on Aug 13, 2026.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for NRXS

Across the 16 sessions after earlier NRXS headlines, the stock closed higher 9 times and lower 7 times, with a median move of 5.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Earlier insider filings at NRXS

Keep researching NRXS

Quantisnow market dataAMEX
Neuraxis Inc. logo
NRXS
Neuraxis Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Listed since
2023
Get push alerts for NRXS

Follow NRXS and get a push notification the moment its next story breaks.

Full NRXS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRXS (Neuraxis Inc.) and more on Quantisnow.